Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06394843
Other study ID # MVVH
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 6, 2024
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source University Hospital, Linkoeping
Contact Joachim Zdolsek, MD
Phone +46101031821
Email joachim.zdolsek@regionostergotland.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

During dialysis, three objectives are achieved. 1. Blood is cleansed from waste products. 2. Excess water is removed. 3. Electrolytes are regulated. These processes occur simultaneously but vary from patient to patient depending on their specific needs. Some patients still produce urine, but of poor quality. Others have no residual urine production at all and require removal of fluid from both blood and tissues. Hypotension may occur during dialysis, related to intravascular hypovolemia and inadequate fluid reinfusion, which is common during ultrafiltration exceeding 400 ml/h. The amount of fluid removed is influenced by fluid recruitment from tissues. This mainly occurs in two different ways: osmotic recruitment across capillary membranes from the perivascular space or via lymphatic reflow. The proportions are not fully understood. When fluid is recruited from the perivascular space, the influx of albumin and immunoglobulins is unlikely. However, these should accompany lymph to the blood if lymphatic flow is increased. The content of albumin and immunoglobulins differs between lymph and plasma. Thus, the proportions of fluid recruitment from tissues should be calculable using mass balance calculations based on ultrafiltrate, colloid osmotic pressure, hemoglobin, albumin, and immunoglobulin concentrations. The rate and proportions of fluid reinfusion into the bloodstream are not fully understood. Therefore, in this study, the aim is to monitor fluid reinfusion and its proportions of lymph/osmotic recruitment into the bloodstream.


Description:

In Sweden, approximately 3200 patients undergo hemodialysis annually. In some cases, it is solely about blood purification, but for many patients, removal of excess fluid accumulated since the last dialysis treatment is also necessary. The amount of fluid removal/ultrafiltration prescribed by the physician during dialysis primarily depends on the amount of residual urine the patient produces but also on the patient's fluid intake between dialysis treatments. The most common complication of hemodialysis is hypotension during treatment, occurring in about 10% of treatment sessions according to previous studies. These hypotensive episodes lead to temporary hypoperfusion, and repeated episodes can cause permanent organ damage. The main cause of these hypotensive episodes is the reduction in circulating volume during ultrafiltration, i.e., fluid removal. The excess fluid that the patient accumulates between treatments is mainly located outside the bloodstream. Therefore, in connection with fluid removal during hemodialysis, there is compensatory fluid recruitment to the circulation, increasing the circulating volume and preventing hypotension. How this occurs and from which fluid compartment fluid is recruited is not yet mapped out. To increase understanding of hemodialysis and optimize treatment while minimizing the risk of hypotension, it is interesting to understand how fluid recruitment occurs and from which fluid compartments recruitment occurs. Using fluid kinetic calculations, it has been possible to measure whether fluid is recruited perivascularly or from the lymphatic system during albumin infusion depending on the concentrations of proteins such as IgG and IgM, as their concentrations differ. By measuring the concentrations of these proteins in blood samples over time, it has been possible to calculate from which fluid compartment fluid has been recruited. Purpose and Objective The aim is to study: - How much fluid is drawn from the interstitial space during dialysis, depending on whether fluid removal is needed or not. - The size and rate of fluid reinfusion during ongoing dialysis. - The composition of the recruited fluid from the interstitium, i.e., the proportion consisting of lymph/lymph reflow and the proportion recruited across capillary membranes/venulae from the pericapillary space. Hypotheses The null hypothesis is that no detectable difference in fluid flows or source of fluid recruitment is found, between patients where a large volume is dialyzed and those patients who do not have significant fluid removal during dialysis. The alternative hypothesis is that a clinical relevant difference in fluid flows from the interstitium and the pathway for fluid recruitment to the bloodstream is detected. Outcome Measures Primary outcome variables are: Recruitment of fluid from the interstitium calculated from fluid removal and hemoglobin changes. Proportion of recruited fluid via lymph or via capillary/venulae walls based on fluid recruitment and changes in plasma albumin and immunoglobulins G and M. Secondary outcome variables are: Weight, blood pressure impact, and changes in bioimpedance variables. Study Design: Open-label, prospective clinical observational study, where patients are divided into two groups. One group with an intact urine production, and dialysis is performed solely to "cleanse" the blood and second group with little or no urine production, which requires significant fluid removal, in addition to blood purification, .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Patients undergoing hemodialysis (<500 ml or >2000 ml ultrafiltration) Exclusion Criteria: - Patients who may be affected by blood sampling, i.e., have low hemoglobin concentration independent of dilution before dialysis (Hb 85 g/L). - Patients who drink large amounts of water during regular dialysis (> 2 glasses, approximately 0.5 L).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ultrafiltration
Patients are selected depending on need of ultrafiltration

Locations

Country Name City State
Sweden Vrinnevi Hospital Norrköping Östergötland

Sponsors (2)

Lead Sponsor Collaborator
Joachim Zdolsek Region Östergötland

Country where clinical trial is conducted

Sweden, 

References & Publications (1)

Zdolsek JH, Zdolsek M, Hahn RG. Recruitment of efferent lymph during infusion of 20 % albumin. Microvasc Res. 2023 Jul;148:104539. doi: 10.1016/j.mvr.2023.104539. Epub 2023 May 6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of fluid recruited via endothelial wall vs lymph Recruitment of fluid from the interstitium calculated from fluid removal and hemoglobin changes. Proportion of recruited fluid via lymph or via capillary/venulae walls based on fluid recruitment and changes in plasma albumin and immunoglobulins G and M 8 hours
Secondary Weight Weight (before and after hemodialysis) 8 hours
Secondary Blood pressure Impact of hypovolemia related to ultrafiltration on blood pressure 8 hours
Secondary Bioimpedance Change in Bioimpedance related to hemodialysis 8 hours
See also
  Status Clinical Trial Phase
Completed NCT04448093 - Relationship Between Quality of Life, Self-image and Oral Health in Patients Undergoing Hemodialysis Early Phase 1